Many experts believe vaccines will likely continue protecting against severe disease, but the mutated variant may prove highly infectious.
Author: Elizabeth Weise and Karen Weintraub, USA TODAY
FDA authorizes booster dose of Pfizer COVID-19 vaccine for people 65 and older, high-risk workers
The FDA authorized COVID booster doses of the Pfizer-BioNTech vaccine for people 65 and older and those whose jobs put them at high risk for exposure.
CDC committee meets today to decide: Who should get COVID-19 boosters first?
The CDC’s advisory group has a difficult task: deciding who really needs a booster dose of COVID-19 vaccine.
Moderna says its COVID vaccine found to be 100% effective in children 12 to 17 two weeks after second dose
The Moderna vaccine was 93% effective against COVID-19 in teenagers aged 12 to 17 after the first dose and 100% two weeks after the second dose.
To protect Americans and help the world, US needs to start giving more COVID-19 vaccine away more quickly, experts say
By quickly donating millions of doses of COVID-19 vaccines and setting an example for other nations, the U.S. could help end the global pandemic.
Pause on Johnson & Johnson COVID vaccine in US lifted by FDA, use to resume
The pause on the one-dose J&J COVID vaccine will be lifted and distribution will resume in the U.S., FDA officials said Friday night.
Vaccine passports should be free, private and secure, White House says. But who will be issuing them?
Israel has a “green card” to prove that people have been vaccinated and other countries are contemplating requiring proof of vaccination for entry.
Amid a chaotic COVID-19 vaccine rollout, states find ways to connect shots with arms
Under a decentralized national health care system and a chaotic COVID-19 vaccine rollout, states find their own ways to reach and vaccinate residents.
A COVID-19 vaccine life cycle: from DNA to doses
Making a vaccine against the coronavirus is a complicated, months-long process. Pfizer is working to get it done faster. It still takes time.
Where did COVID-19 come from?
As the U.S. marks one year since its first case, questions remain about the origin of the coronavirus that causes the disease. The answers matter.